Post hoc Analysis of Clinical Outcomes in Placebo- and Pirfenidone-Treated Patients with IPF Stratified by BMI and Weight Loss.

Stéphane Jouneau,Bruno Crestani,Ronan Thibault,Mathieu Lederlin,Laurent Vernhet,Ming Yang,Elizabeth Morgenthien,Klaus-Uwe Kirchgaessler,Vincent Cottin

Respiration; international review of thoracic diseases（2021）

引用 13|浏览17

暂无评分

摘要

Patients with a baseline BMI <25 kg/m2 or annualized weight loss of >0-<5% or ≥5% may experience worse outcomes over 1 year versus those with a baseline BMI ≥25 kg/m2 or no weight loss.

查看译文

关键词

Body composition,Body mass index,Idiopathic pulmonary fibrosis,Interstitial lung disease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要